We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+14.93%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.49B
AUM Growth
-$310M
Cap. Flow
-$220M
Cap. Flow %
-4%
Top 10 Hldgs %
20.85%
Holding
223
New
43
Increased
76
Reduced
62
Closed
19

Top Buys

Rank Stock Value
1
GEV icon
GE Vernova
GEV
+$78M
2
DTM icon
DT Midstream
DTM
+$57.2M
3
WDAY icon
Workday
WDAY
+$50.1M
4
LNG icon
Cheniere Energy
LNG
+$48M
5
BPMC
Blueprint Medicines
BPMC
+$47M

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$95.2M
2
WCN
Waste Connections
WCN
+$90.6M
3
TT icon
Trane Technologies
TT
+$86.8M
4
DHI icon
D.R. Horton
DHI
+$68.1M
5
ROL icon
Rollins
ROL
+$57.3M

Sector Composition

Rank Sector Weight
1 Healthcare 37.19%
2 Technology 20.42%
3 Industrials 16.23%
4 Consumer Discretionary 7.92%
5 Energy 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NI icon
126
NiSource
NI
$21.6B
$12.2M 0.22%
+331,555
New +$11.9M
CYTK icon
127
Cytokinetics
CYTK
$10.9B
$12M 0.22%
254,148
– –
CBT icon
128
Cabot Corp
CBT
$4.55B
$11.5M 0.21%
126,317
+3,497
+3% +$376K
RLAY icon
129
Relay Therapeutics
RLAY
$4.24B
$11.1M 0.2%
2,682,083
– –
RNAM
130
DELISTED
Avidity Biosciences
RNAM
$10.9M 0.2%
375,924
– –
PRCT icon
131
Procept Biorobotics
PRCT
$1.02B
$10.1M 0.18%
124,874
-4,126
-3% -$352K
RCKT icon
132
Rocket Pharmaceuticals
RCKT
$351M
$9.69M 0.18%
770,691
– –
IT icon
133
Gartner
IT
$10.2B
$9.46M 0.17%
+19,531
New +$10.1M
SPGI icon
134
S&P Global
SPGI
$122B
$8.78M 0.16%
17,622
+563
+3% +$286K
DVAX
135
DELISTED
Dynavax Technologies
DVAX
$8.6M 0.16%
673,810
– –
LIN icon
136
Linde
LIN
$235B
$8.4M 0.15%
20,066
+1,258
+7% +$573K
DELL icon
137
Dell
DELL
$262B
$8.27M 0.15%
71,827
-15,214
-17% -$1.91M
LXEO icon
138
Lexeo Therapeutics
LXEO
$342M
$8.13M 0.15%
1,234,834
-621,152
-33% -$4.89M
SNV
139
DELISTED
Synovus
SNV
$8.11M 0.15%
158,279
+25,019
+19% +$1.3M
MANH icon
140
Manhattan Associates
MANH
$11.1B
$8.1M 0.15%
29,960
+22,261
+289% +$6.34M
BRKR icon
141
Bruker
BRKR
$9.79B
$7.95M 0.14%
135,635
+4,792
+4% +$283K
DYN icon
142
Dyne Therapeutics
DYN
$4.8B
$7.83M 0.14%
332,277
– –
NVDA icon
143
NVIDIA
NVDA
$4.72T
$7.24M 0.13%
53,788
+9,425
+21% +$1.3M
HD icon
144
Home Depot
HD
$332B
$6.95M 0.13%
17,856
+7,421
+71% +$3.03M
AVGO icon
145
Broadcom
AVGO
$1.85T
$6.7M 0.12%
+28,777
New +$5.32M
QTRX icon
146
Quanterix
QTRX
$166M
$6.54M 0.12%
+615,000
New +$7.48M
NOW icon
147
ServiceNow
NOW
$114B
$6.19M 0.11%
29,185
+1,425
+5% +$289K
NKTR icon
148
Nektar Therapeutics
NKTR
$2.41B
$6.18M 0.11%
443,333
-183,334
-29% -$3.23M
INZY
149
DELISTED
Inozyme Pharma
INZY
$6.15M 0.11%
2,220,000
-1,914,436
-46% -$7.28M
AXP icon
150
American Express
AXP
$228B
$6.07M 0.11%
+20,446
New +$5.87M
4 5
6
7 8

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Eventide Asset Management held 223 positions worth $5.49B, down 5.3% from $5.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Eventide Asset Management withdrew a net $220M in Q4 2024, closing 19 positions and reducing 62 holdings. Its most notable exit was Idexx Laboratories, an estimated $95.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

Against the trend, Eventide Asset Management opened a new position in GE Vernova worth $82.1M.

  • Eventide Asset Management's largest Q4 2024 buy was GE Vernova: 249,514 shares worth $82.1M.
  • Eventide Asset Management added most to Workday in Q4 2024, an estimated $50.1M increase.
  • Eventide Asset Management's biggest Q4 2024 reduction was Waste Connections, cutting an estimated $90.6M.
  • Eventide Asset Management fully exited Idexx Laboratories in Q4 2024, selling an estimated $95.2M.
  • Eventide Asset Management's ten largest holdings make up 21% of its $5.49B portfolio in Q4 2024.
  • Eventide Asset Management opened 43 new positions and closed 19 in Q4 2024.
  • Eventide Asset Management's portfolio value fell 5.3% quarter-over-quarter to $5.49B.

Based on Eventide Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.